Effects of meloxicam on plasma iohexol clearance as a marker of glomerular filtration rate in conscious healthy cats

American Journal of Veterinary Research

Volumn 70, Issue 7, 2009, Pages 826-830

  Goodman, Laura A ^a   Brown, Scott A ^a   Torres, Bryan T ^a   Reynolds, Lisa R ^a   Budsberg, Steven C ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IOHEXOL; MELOXICAM;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CAT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG POTENTIATION; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; SODIUM RESTRICTION;

ANIMALS; BIOLOGICAL MARKERS; CATS; CONTRAST MEDIA; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; GLOMERULAR FILTRATION RATE; IOHEXOL; MALE; THIAZINES; THIAZOLES;

ANIMALIA;

EID: 67651229260     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.7.826     Document Type: Article

References (26)

1. Yang T, Singh I, Pham H, et al. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol 1998;274:F481-F489.
2. Roig F, Llinas MT, Lopez R, et al. Role of cyclooxygenase-2 in the prolonged regulation of renal function. Hypertension 2002;40:721-728.
3. Llinas MT, Lopez R, Rodriguez F, et al. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Am J Physiol Renal Physiol 2001;281:F975-F982.
4. Terragno NA, Terragno DA, McGiff JC. Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and laparotomized dogs. Circ Res 1977;40:590-595.
5. Blasingham MC, Nasjletti A. Differential renal effects of cyclooxygenase inhibition in sodium-replete and sodium-deprived dog. Am J Physiol 1980;239:F360-F365.
6. Blasingham MC, Shade RE, Share L, et al. The effect of meclofenamate on renal blood flow in the unanesthetized dog: relation to renal prostaglandins and sodium balance. J Pharmacol Exp Ther 1980;214:1-4.
7. Al-Gizawiy MM, Rudé EP. Comparison of preoperative carprofen and postoperative butorphanol as postsurgical analgesics in cats undergoing ovariohysterectomy. Vet Anaesth Analg 2004;31:164-174.
8. Carroll GL, Howe LB, Peterson KD. Analgesic efficacy of preoperative administration of meloxicam or butorphanol in onychectomized cats. J Am Vet Med Assoc 2005;226:913-919.
9. Lascelles BD, Hansen BD, Roe S, et al. Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis. J Vet Intern Med 2007;21:410-416.
10. Chapnick BM, Paustian PW, Feigen LP, et al. Influence of inhibitors of prostaglandin synthesis on renal vascular resistance and on renal vascular responses to vasopressor and vasodilator agents in the cat. Circ Res 1977;40:348-354.
11. Harris RC, McKanna JA, Akai Y, et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994;94:2504-2510.
12. Khan KN, Venturini CM, Bunch RT, et al. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol 1998;26:612-620.
13. Nantel F, Meadows E, Denis D, et al. Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly. FEBS Lett 1999;457:475-477.
14. Sellers RS, Senese PB, Khan KN. Interspecies differences in the nephrotoxic response to cyclooxygenase inhibition. Drug Chem Toxicol 2004;27:111-122.
15. Khan KN, Stanfield KM, Harris RK, et al. Expression of cyclooxygenase-2 in the macula densa of human kidney in hypertension, congestive heart failure, and diabetic nephropathy. Ren Fail 2001;23:321-330.
16. Adegboyega PA, Ololade O. Immunohistochemical expression of cyclooxygenase-2 in normal kidneys. Appl Immunohistochem Mol Morphol 2004;12:71-74.
17. Dammagen J. The use of metacam 0.5 mg/ml oral suspension in cats with osteoarthritis, in Proceedings. Metacam Symp Arthritic Dis Cats 2007;19-20.
18. Miyamoto K. Use of plasma clearance of iohexol for estimating glomerular filtration rate in cats. Am J Vet Res 2001;62:572-575.
19. Miyamoto K. Clinical application of plasma clearance of iohexol on feline patients. J Feline Med Surg 2001;3:143-147.
20. Finco DR, Braselton WE, Cooper TA. Relationship between plasma iohexol clearance and urinary exogenous creatinine clearance in dogs. J Vet Intern Med 2001;15:368-373.
21. Finco DR, Brown SA, Crowell WA, et al. Exogenous creatinine clearance as a measure of glomerular filtration rate in dogs with reduced renal mass. Am J Vet Res 1991;52:1029-1032.
22. Brown SA, Haberman C, Finco DR. Use of plasma clearance of inulin for estimating glomerular filtration rate in cats. Am J Vet Res 1996;57:1702-1705.
23. Miyamoto K. Evaluation of plasma clearance of inulin in clinically normal and partially nephrectomized cats. Am J Vet Res 2001;62:1332-1335.
24. Goy-Thollot I, Besse S, Garnier F, et al. Simplified methods for estimation of plasma clearance of iohexol in dogs and cats. J Vet Intern Med 2006;20:52-56.
25. Goy-Thollot I, Chafotte C, Besse S, et al. Iohexol plasma clearance in healthy dogs and cats. Vet Radiol Ultrasound 2006;47:168-173.
26. Laroute V, Lefebvre HP, Costes G, et al. Measurement of glomerular filtration rate and effective renal plasma flow in the conscious beagle dog by single intravenous bolus of iohexol and p-aminohippuric acid. J Pharmacol Toxicol Methods 1999;41:17-25.